The European Medicines Agency says it is confident that it can secure EU approval of “at least a majority” of the candidate COVID-19 vaccines currently under rolling review at the EMA by the end of the year or the beginning of 2022.
The announcement was made at a press briefing on 9 September, where the EMA also gave an update on progress...








